Investigation on Consequences of Autoimmunity with Regard to Quality of Life in Patients with Checkpoint Inhibitor Therapy compared to Patients with Autoimmune Disease (2021) Schulz TU, Zierold S, Akcetin SL, Pesch G, French LE, Heinzerling L Conference contribution YouTube (R)-Videos about Skin Cancer as an Information Source for Patients: Assessment of quality, Comprehensibility and Reliability (2021) Reinhardt L, Steeb T, Harlass M, Brutting J, Berking C, Meier F Conference contribution The Nectin-1 Expression correlates with the Susceptibility of malignant Melanoma to oncolytic Herpes Simplex Viruses in vitro and in vivo (2021) Schwertner B, Linder G, Stauner CT, Klapproth E, Magnus C, Rohrhofer A, Gross S, et al. Conference contribution Acute demyelinating Polyradiculoneuropathy with CSF Pleocytosis under Therapy with BRAF/MEK Inhibitor in advanced malignant Melanoma (2021) Hecker C, Madzar D, Schultz E, Debus D Conference contribution A novel antiproliferative, pro-apoptotic Approach for the Treatment of actinic Keratoses: Tirbanibulin (KX2-391) (2021) Heppt M, Ocker WG, Melzer A Conference contribution Analysis of IFN gamma-mediated Transcriptome Changes in Merkel Cell Carcinoma Cell Lines via Nanopore Sequencing (2021) Sauerer T, Lischer C, Berking C, Vera-Gonzalez J, Dörrie J Conference contribution Rapid Response of locally distinct CD30 positive primary cutaneous anaplastic large T-Cell Lymphoma under Brentuximab Vedotin (2021) Bender-Säbelkampf S, Berking C, Erdmann M Conference contribution The Role of NRN1 in the Development and Progression of malignant Melanoma (2021) Haller L, Reichelt J, Boßerhoff AK, Kuphal S Conference contribution Does In-transit-Metastasis in lower Extremity Melanoma Patients correlate with anatomical Lymphatic Drainage Pathways? (2021) Müller K, Schellerer V, Berking C, Erdmann M Conference contribution The Role of the Transcription Factor AP2e in the Development of malignant Melanoma (2021) Stabler S, Rottensteiner-Brandl U, Boßerhoff AK Conference contribution